ImmunityBio director Simon Barry J. has sold shares valued at $165,305. The transaction details beyond the sale value were not disclosed.
Insider selling can sometimes signal a lack of confidence in a company's future prospects, potentially influencing investor sentiment.
ImmunityBio director Simon Barry J. has sold shares of the company's stock. The total value of the transaction amounted to $165,305. Further specific details regarding the sale, such as the number of shares or the price per share, were not provided in the disclosure.
Pick the topics you care about. Get only what matters, on your cadence.
Twenty-one names where option premium moved away from its own normalhome.saxoTrading stocks, CFDs, spread betting, futures, and options involves a high level of risk and may not be suitable for all investors. Prices can move rapidly, and losses can occur quickly and exceed your expectations.